Connection

Maurizio Sanguinetti to Biomarkers

Back to Details
This is a "connection" page, showing publications Maurizio Sanguinetti has written about Biomarkers.
Maurizio Sanguinetti
Connection Strength
0.076
Biomarkers
  1. Gut Microbiota in Health, Diverticular Disease, Irritable Bowel Syndrome, and Inflammatory Bowel Diseases: Time for Microbial Marker of Gastrointestinal Disorders. Dig Dis. 2018; 36(1):56-65.
    View in: PubMed
    Score: 0.033
  2. The role of procalcitonin outside of the Intensive Care Unit (ICU): a multidisciplinary approach. Eur Rev Med Pharmacol Sci. 2019 Apr; 23(7):2978-2985.
    View in: PubMed
    Score: 0.009
  3. Influence of hepatitis C virus eradication with direct-acting antivirals on the gut microbiota in patients with cirrhosis. Aliment Pharmacol Ther. 2018 12; 48(11-12):1301-1311.
    View in: PubMed
    Score: 0.009
  4. Combined use of Quantiferon and HBHA-based IGRA supports tuberculosis diagnosis and therapy management in children. J Infect. 2018 12; 77(6):526-533.
    View in: PubMed
    Score: 0.009
  5. Combined use of serum (1,3)-ß-D-glucan and procalcitonin for the early differential diagnosis between candidaemia and bacteraemia in intensive care units. Crit Care. 2017 Jul 10; 21(1):176.
    View in: PubMed
    Score: 0.008
  6. Intensive care medicine research agenda on invasive fungal infection in critically ill patients. Intensive Care Med. 2017 Sep; 43(9):1225-1238.
    View in: PubMed
    Score: 0.008
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.